Week 2B: Glycogen metabolism and membrane transporters Flashcards

HC 11-14

You may prefer our related Brainscape-certified flashcards:
1
Q

Structure free glucose

A

Contains a very polarized reactive aldehyde group
/H
-C (delta plus) = O (delta minus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The aldehyde group can react with (in vitro, in vivo, intramolecular)

A

In vitro: Fehlings reagent (Cu2+ ions)
In vivo: amino groups of proteins
Intramolecular: with the C5 hydroxyl group (count from aldehyde, so opposite one) > form ring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Glucose is a …. sugar

A

reducing
> can reduce Cu2+ to Cu+ in vitro
> aldehyde group is oxidized to carboxyl group (C(=O)-OH) > gluconic acid
> reducing sugars need free reducing ends

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Fehlings test for reducing sugars

A

Solution of Cu2+ (Fehlings reagent) used in vitro to distinguish reducing and nonreducing sugars.
> glucose and fructose are reducing sugars
> Reducing Cu2+ to Cu+
> 2 Cu+ react with water to form Cu2O (red precipate, red/brown color)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A reducing sugar can reduce a …

A

another molecule while being oxidized themselves from a sugar with an aldehyde group to a carboxyl group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Two ways of adding glucose to proteins

A

-Glycosylation: enzymatic transfer of glucose in condensation reaction
-Glycation: nonenzymatic spontaneous and irreversible transfer of glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Glycation in vivo

A

Takes place in vivo between glucose and free amino groups of proteins, such as abundant proteins serum albumin and hemoglobin.
> formation of reversible Schiff base
> conversion to stable ketoamine (irreversible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Glycation of hemoglobin

A

-Aldehyde group of glucose reacts with N-terminus of the N-terminal Valine residue of HbA (spontaneous reversible)
> formation Schiff base: C(-H)=N-Val-HbA
> Amadori rearrangement (irreversible, spontaneous)
> HbA1c: C1 of glucose like this: C(=O)-H2C(nr1)-N(H)-Val-HbA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Schiff base bond

A

-C=N-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is it possible that the amino terminus of HbA beta chain (tetramer with two alpha and beta chains) is valine and not methionine

A

Hydrolysis of the N-terminal residue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Glycation of HbA at the..

A

alpha-amino group of this amino-terminal valine residue of HbA beta chain
> in lesser extent at amino groups at lysine side chains in alpha and beta chains of hemoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Does the glycation of HbA to HbA1c impact the function of hemoglobin

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The rate of glycation of hemoglobin is proportional to…

A

blood glucose concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Normal HbA1c/HbA% level

A

5.5%, when hyperglycemia, this can rise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The glycation of stable colagen (ECM protein) increases with …

A

age
> resembles Maillard reaction in food cooking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The aldehyde group of glucose can react intramolecularly with the c5 hydroxyl group. In which ways

A

-alpha glucose: c1 hydroxyl group faces away of the oxygen in the chain (36% prevalence)
-beta-glucose: hydroxyl group on C1 faces towards the O (from the C5 hydroxyl group) in the ring
> the cyclic alpha and beta anomers (different conformations of the aldehyde group C1 of glucose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The conformation of the hydroxyl group on C1 on the cyclic glucose isoforms are called:

A

Alpha- Axial
Beta- Equatorial, in line with molecule (horizontal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Glycosylation of glucoses

A

During enzym-catalyzed reaction, cyclic glucose forms stable covalent glycosidic bond via its C1 anomeric position

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Glycosidic bond

A

reducing end Glucose C1 - O - C4 glucose nonreducing end

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

After glycosylation, the intrachain glucose cannot ..

A

adopt an open-chain form anymore

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How is a linear homopolymer of glucose residues called?

A

Glucan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

In a glucan, a free reducing end can adopt an open chain formation and keep reducing. In an alpha-1,4-glucan. What is the reducing end?

A

The end with the free C1 carbon (aldehyde group, reactive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Initiation formation of proteo-glycogen

A

Start with glycogenin (GN), the initiator/primer.
> GN is a homodimer and both monomers can glycosylate each other
> each GN monomer is glycosylated specifically on a single tyrosine residue (with the benzene ring with OH group, which forms a bond with the reducing (C1) end of glucose).
> Auto-glycosylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How long does auto-glycosylation of the GN monomers take place?

A

Until maximally 8 glucose residues added per glycogenin
> monomers dissociate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Elongation glucose chain on glycogenin

A

By enzyme glycogen synthase (GS)
> GS is a processive enzyme
> Extends existing chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Branchin in proteo-glycogen

A

Branchin enzyme (BE) removes an oligosaccaride of 7 glucose residues from the nonreducing end (within the growing chain, 7 glucoses from the reducing, growing end)
> transfer the oligosaccharide to create a new branch point which is at least 4 glucose residues away from a preexisting branch point upstream.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Growth glycogen idea model of Whelan

A

Growth by glycogen synthase and branching enzyme: forming shells
> Shells: layers of glucose chains created by new branching. Count the branch points from start to end > three branch point till reaching end: four shells (model of Whelan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Mature glycogen is sphere with about .. shells. It consists of linear units of …-glucose residues. Each glycogen unit has averagely .. branch points connected through … bonds

A

tmax= 12, g-c=13, r=2
> 12 shells maximally
> linear units of 13 alpha-glucose, connected through (1-6)-alpha-glycosidic bonds
> 2 branch points per glycogen unit on average

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

The nonreducing ends of glycogen are located at …

A

the termini of the outer most shell, forming the surface of the glycogen molecule
> excellent acces for glycogen modifying enzymes
> Glycogenin enzyme located in centre of proteoglycogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Where are glycogen granules localized?

A

in the cytosol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How is glycogen metabolism regulated in the liver and muscle?

A

-Liver: glycogen metabolism is regulated to maintain the blood glucose level
-Muscle: glycogen metabolism is used to maintain its own energy requirements (lacks G6Pase) (much glycogen from subsarcolemma glycogen granules compared to myofibrilar glycogen granules before exercise.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

HC12: Glycogen synthase catalyzes …. by using … as a substrate

A

addition of glucose residues (alpha) at the nonreducing end of growing glycogen chain.
Substrates: [glucose]n (growing glycogen) + UDP-glucose > [glucose]n+1 + UDP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Structure UDP-glucose

A

Activated form of glucose (like acetyl-CoA is activated form of acetate) > contains high energy phosphoanhydride bond (1) which favors the reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

UDP-glucose synthesis

A

Glucose 1-phosphate + UTP > UDP-glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Linkages between glucose residues in linear chain glycogen and at a branch point

A

In linear chain: alpha-1,4-glycosidic bond
In branch point: alpha-1,6-glycosidic bond

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

How many ATP costs the linkage of one glucose from blood to glycogen

A

2 ATP, one to regenerate UTP from UDP, and one to activate glucose to glucose-1-P via G-6-P.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Cleavage of a bond by addition of Pi

A

Phosphorolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How is a glucose residue removed from glycogen at the nonreducing end

A

Adding a phosphate to the reducing end to free it
> phosphorolysis by Glycogen phosphorylase (GP) > needs Pi as cosubstrate
- [glucose]n+1 + Pi > [glucose]n + G-1-P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Debranching enzyme of glycogen

A

By debranching enzyme
> bifunctional enzyme with transferase activity and alpha-1,6-glycosidase activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Debranchin glycogen

A

-Phosphorylase cleaves all glucose until the original chain and branch have 4 glucose left until branch glucose unit. (using Pi, release glucose as G-1-P)
-Transferase (only works when 4 glucose left till branch linkage) remodels so that the outer three glucose units from the branch chain are transferred to the original chain
-a-1,6-glucosidase uses H2O to remove last glucose unit of branch
-phosphorylase can cleave bonds until next branch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

How is the glucose cleaved by a-1,6-glucosidase during glyccogenolysis released?

A

As free glucose
> glucose units at branch points
> free glucose are phosphorylated by glucokinase (liver) or hexokinase (muscle)
> costs extra ATP.
> 1 in 10 glucose residues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Glycogenolysis components

A

1: release of G-1-P
2: remodeling of glycogen
3: conversion of G-1-P to G-6-P (by phosphoglucomutase)
4: production of free glucose (liver and kidney) from G-6-P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Fates G-6-P

A

-Glycolysis, in muscle, brain or red blood cells (example)
-Conversion to glucose in liver or kidney (for other organs)
-PPP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Conversion by phosphoglucomutase

A

G-1-P binds the phosphorylated serine’s phosphate group at C6
> formation intermediate: glucose-1,6-bisphosphate
> Serine of the enzyme binds phosphate group of the C1 carbond
> glucose-6-P as product

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Glucose producers and consumers

A

Producers: liver and kidneys (contain glucose-6-phosphatase)
-Consumers: brain, adipocytes, erythrocytes, muscle cells

46
Q

Different rates of glycogen breakdown in different exercise

A

Highest rate in highest intensity (150% of teh intensity at VO2max maximal oxygen consumption)

47
Q

When glycogen use in fasted state?

A

During first day (short term response, <12 hrs)

48
Q

HC13: which type of glucose synthesis mechanism is used early in the morning

A

Gluconeogenesis (after long period withour meal)

49
Q

Regulation types in glycogen metabolism

A

-Hormones (control from outside the cell: insulin, glucagon, adrenaline): (de)phosphorylation
-Metabolites (AMP/ATP, G-6-P, glucose: control from within the cell): allosteric regulation

50
Q

Epinephrine origin

A

It is a catecholamine, derived from the amino acid tyrosine (ring with OH in structure) (but contains no amino acids)
> promotes glycogen breakdown
> fight or flight

51
Q

Structure of glycogen phosphorylase

A

-Homodimer

52
Q

Prosthetic group GP

A

Pyridoxal phosphate (PLP) group bound via Schiff base linkage (aldehyde to amino bond with -HC=NH-) to a lysine residue (epsilon amino group)

53
Q

PLP is vitamin?

A

Vitamin B6

54
Q

PLP function in GP

A

> contributes to binding of inorganic phosphate for phosphorolysis.
is more energy efficient than breakdown of glucose and phosphorylation by Hexokinase using ATP.
PLP group with its phosphate crucial to bring phosphate into position for catalysis

55
Q

Glucagon has an important … residue

A

N-terminal Histidine, important in activation mechanism of the receptor

56
Q

Isoforms of glycogen phosphorylase

A

phosphorylase-a: phosphorylated: often active (in R-state)
phosphorylase-b: dephosphorylated: often less active (in T-state)

57
Q

How does phosphorylation of GP induce active enzyme

A

water shell is formed around the phosphate: conformational change.

58
Q

R-state and T-state jargon also applies to…

A

hemoglobin.

59
Q

Can the a and b formd of GP exist in both the relaxed and less active tense state?

A

Yes, but mostly b in T and a in R –> but allosteric regulation overrules the phosphorylation/hormonal regulation

60
Q

When does GP-b change to GP-a

A

From fed to fasted state

61
Q

How many encoded GP enzymes?

A

Two isozymes
-Muscle GP
-Liver GP
> mostly similar
> different (metabolite) regulations

62
Q

Allosteric regulation liver GP

A

The liver GP-a form undergoed R>T transition when glucose binds, inactivating it and overruling the phosphorylation state at the two tails of the homodimer.

63
Q

Allosteric regulation of muscle GP

A

At low energy (high AMP/ATP), favors the transition to R-state.
> high concentrations of ATP or G-6-P: shift muscle-GP to T-state

64
Q

Hormonal regulation liver GP and muscle GP

A

-Liver GP
> activation by glucagon and adrenaline
-Muscle GP
> activation by adrenaline and calcium (nerve excitation)
> Muscle has no glucagon receptors.

65
Q

ATP can bind to … of GP in the … isozyme

A

Nucleotide binding sites in the muscle isozyme

66
Q

Is glycolysis upregulated by glucagon in the muscle?

A

No, it has no glucagon receptors
> does react to adrenaline

67
Q

effect epinephrine to liver lactate which came in from muscle

A

Gluconeogenesis in fasted state. (glucagon rules)

68
Q

How does glucagon initiate activation of GP and inactivation of GS (reciprocal regulation)

A

Glucagon signaling: PKA active.
PKA phosphorylates GS: to T state
PKA phosphorylates glycogen phosphorylase kinase (activation)
GP kinase phosphorylates and activated GP

69
Q

Why extra step throug GP-kinase

A

Extra layer of regulation
> phosphorylase kinase can be only be activated by Ca2+ in the muscle (excitation)
> GP-kinase has delta subunits: Ca2+ sensor calmodulin: binds Ca2+ > alpha and beta subunits can be phosphorylated by PKA.

70
Q

Regulation glycogen synthase by PP1

A

PP1: protein phosphatase 1(dephosphorylation)
> PP1 inactivates phosphorylase kinase and therefore GP
> PP1 activates GS
> PP1 dephosphorylates GP directly as well

71
Q

Regulation by PP1 in muscle and structures/interaction

A

Catalytic subunit of PP1 is active while bound to regulatory subunit Gmuscle.
> PKA phosphorylates Gmuscle, PP1 released, becomes less active
> PKA phosphorylates and activates an inhibitor of PP1 as well
> result: GP and GS can shift to phosphorylated form and GP active and GS inactive

72
Q

Regulation PP1 in liver

A

Catalytic subunit PP1 bound to regulatory subunit Gliver
> glucose brings GP in T-state, allowing PP1 to dephosphorylate and inactivate GP: glucose is bound to Gliver, Gliver releases. Free PP1 is active in the liver (Gliver is inhibitor).
>Free PP1 inactivates GP but activates GS

73
Q

Effect insulin on glycogen metabolism

A

Insulin binds and activates intracellular protein kinases like PKB/Akt
> kinases phosphorylate and inactivate glycogen synthase kinase, thereby inactivating kinase activity (no inhibition GS).
> this allows PP1 to dephosphorylate and activate GS

74
Q

How much ATP costs GP-b > GP-a

A

2 ATP, 2 times phosphorylation.

75
Q

Infusion of blood glucose in blood stream leads to this transition in glycogen metabolism enzymes

A

-Inactivation of GP first, followed by activation of GS.
> activation GS through insulin (longer)
> inactivation of GP by glucose allosterically: directly

76
Q

Glycogen storage diseases: defect in Von Gierke

A

Defect G6Pase
> liver and kidneys

77
Q

Pompe disease defects

A

a-1,4-glucosidase (and therefore glycogen breakdown)
> all organs
> part of the debranching enzyme

78
Q

Andersen disease enzyme defect

A

Defect branching enzyme
> liver and spleen

79
Q

McArdle disease defect

A

Glycogen phosphorylase
> in muscle: only muscle isozyme affected

80
Q

McArdle disease complication

A

strenuous exercise cause painful cramps, reversible: relief after a while
> no glycogen breakdown, no release of myosin in muscle
> muscle goes over to other reserves: you ok again: ATP regeneration by exercise: anaerobic and aerobic metabolism.

81
Q

Cellular symptom Pompe disease

A

Lysosomes full of glycogen
> no breakdown
> only little breakdown percentage in lysosomes, most in cytosol but this is defect in Pompe disease.

82
Q

HC14: Why were membrane proteins hard to study?

A

-Hard to crystallize
-We cannot predict 3D structures from amino acid sequence

83
Q

Revolutions in protein studying

A

-Alphafold predictions
-Cryo-EM (crystallizing not needed)

84
Q

Driving force and transport mechanism to enter enterocytes, example Ca2+

A

No driving force (dG=0) > no net transport
> electrochemical gradient
> Ca2+ is positive, charge membrane is -70mV

85
Q

dG and dribing force

A

dGinward = RTln(Cin/Cout) + ZFdV
Z= charge molecule
>
dG < 0: driving force for transport
dG=0: equilibrium
dG > 0: requires active transport, simply add dG of coupled reaction

86
Q

What is a drug is not charged. When is active transport needed?

A

When the concentration in plasma is lower than intracellular.
dGinward > 0
> 310K as body temperature (37 K + 273 K)
> dV is membrane potential -70 mV > -70/1000 V
> F and R are constants

87
Q

is an equilibrium reached for massive fluxes across epithelia

A

No, driving force for transport remains

88
Q

Characteristics channels and transporters

A

-Both regulated, high variation in max transporters, several mix-forms found.

89
Q

If Na+ is replaced with a neutral molecule and drug transport is abolished then …

A

probably cotransport drug and Na+

90
Q

Channel activity measured with

A

Patch-clamp measurement

91
Q

Types of transporters

A

-Facilitated diffusion (passive)
-Symporters
-Antiporters
-ATP-hydrolysis driven.

92
Q

Properties of transporters

A

-Saturable
-Inhibitable
-Temperature sensitive

93
Q

Methods in transporter research

A

-Transwell plate
-Inside out vesicles (extracellular leaflet switched to inside)

94
Q

Difference carrier mediated transport and simple diffusion on kinetics

A

Carrier mediate: hyperbolic
Diffusion: linear

95
Q

Rate of transport

A

Uptake per time unit

96
Q

About … % of human genes are transporter related and about … % of them are transporters/channels themselves

A

10%, 50%

97
Q

SLC superfamily

A

Solute Carrier (400 members)
> SLCs do not directly rely on ATP hydrolysis

98
Q

ABC transporters

A

(49 genes)
ATP binding cassette transporters family
> rely on ATP hydrolysis
1: bind substrate
2: bind ATP: conformational change and release substrate
3: hydrolysis to ADP and Pi
4: release and reset

99
Q

P-type ATPases

A

Covalent phosphorylation of catalytic aspartate
> ATP dependent
> transport, Na+/K+, H+, Ca2+, Mg2+, phospholipids, heavy metals

100
Q

What happens to Abcg2-/- mice when fed diet containing pheophorbide a?

A

Ear lesions
> fungal breakdown product of chlorophyll: pheophorbide a
> fermened batch of alfalfa

101
Q

Abcg2 function

A

Secretion product into the bile (for excretion) by the liver or from the portal vein directly back.

102
Q

Name an anticancer drug affected by membrane transporters?

A

Abcb11 > resistance against ivermectin

103
Q

What if defect Abcb11?

A

Dose of ivermectin against cancer should drop, less resistance against the drug

104
Q

Drug-drug interactions and transporters example cerivastatin and gemprifozil

A

Gemprifozil inhibits OATP1B1 > less statin metabolism
> increase plasma concentration of cerivastatin > lethal

105
Q

Why can anti-cancer drugs by less effective

A

-Activation DNA repair genes
-Blocked apoptosis
-Activation of detoxifying systems (CYP)
-Decreased influx
-Increased efflux by ATP dependent efflux pumps.

106
Q

What is NTCP

A

A symporter which is present in only the liver and facilitates cotransport of sodium with bile acids

107
Q

NTCP functions (influx bile acids)

A

-Bind bile acid receptors like TGR5: >Glucagon-like peptide 1 secretion > improved glucose metabolism
> Less inflammation
> increased energy expenditure via brown adipose tissue.
-Bile acids bind FXR in nucleus:
> less inflammation, less fibrosis, less gluconeogenesis, reduced FXR signaling in NAFLD.

108
Q

How to inhibit NTCP

A

Gene therapy with virus HBV which can use NTCP as docking receptor ,
or Myrcludex B

109
Q

NTCP KO leads to … conjugated bile acid

A

much more

110
Q

NTCP inhibition by Myrcludex B induces … i obese mice

A

body weight loss in obese mice

111
Q

What happens to bile acids in blood when NTCP is downregulated

A

> it stays longer in the blood after meal and later a decline

112
Q

Peptidic NTCP: NTCPi has a clinical application. Result inhibition NTCPi

A

reduced
-obesity
-steatosis
-atherosclerosis
-inflammation